253
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The role of ADAM-like decysin 1 in non-eosinophilic chronic rhinosinusitis with nasal polyps

, , , , , , , , , & show all
Pages 830-836 | Received 11 Apr 2018, Accepted 18 May 2018, Published online: 23 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomoko Kumagai, Shuangqi Fan & Andrew Mark Smith. (2020) ADAMDEC1 and Its Role in Inflammatory Disease and Cancer. Metalloproteinases in Medicine 7, pages 15-28.
Read now

Articles from other publishers (3)

Le Kang, Chengqian Dai, Lihong Wang & Xinling Pan. (2022) Potential biomarkers that discriminate rheumatoid arthritis and osteoarthritis based on the analysis and validation of datasets. BMC Musculoskeletal Disorders 23:1.
Crossref
S. Lygeros, G. Danielides, K. Grafanaki & M. Riga. (2021) Matrix metalloproteinases and chronic rhinosinusitis with nasal polyposis. Unravelling a puzzle through a systematic review. Rhinology journal 0:0, pages 0-0.
Crossref
Seong Beom Ahn, Samridhi Sharma, Abidali Mohamedali, Sadia Mahboob, William J. Redmond, Dana Pascovici, Jemma X. Wu, Thiri Zaw, Subash Adhikari, Vineet Vaibhav, Edouard C. Nice & Mark S. Baker. (2019) Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel. Clinical Proteomics 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.